You are here: » News


Impaired vision increases risk of depression in midlife women

Midlife women are known to have the highest prevalence of depression compared with all other age groups, and women have higher depression rates than men.

New kind of artificial lens may help patients avoid glasses after cataract surgery

Cataract surgery is one of the most successful medical procedures performed in the United States, with nearly 4 million Americans choosing to have their cataracts removed every year. While the procedure has a success rate of about 97 percent, it is not uncommon for people to still need glasses after surgery, especially reading glasses.

Clinical trial gives hope of new treatment for aggressive eye cancer

A potentially game-changing trial involving University of Liverpool researchers has shown how an immunotherapy drug can prolong the life of patients with an aggressive form of eye cancer.

2021 Best Program results: Wilmer Eye Institute grabs top spot

The year 2021 saw the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, snaring the top spot in the Overall Best Program category.

RetinAward 2021 for Mathieu Quinodoz

Mathieu Quinodoz, bioinformatics researcher in our Ophthalmic Genetics Group led by Carlo Rivolta, wins CHF 30 000 to support his project: «Increasing the molecular diagnostic rate of inherited retinal degenerations and other retinal diseases by combining high-throughput sequencing with an extensive analytical pipeline».

Antidepressant Prozac could offer the first treatment for atrophic macular degeneration

An antidepressant best known as Prozac could offer the first treatment for the leading cause of blindness among people over 50, new research from the University of Virginia School of Medicine suggests.

Australia's first snapshot of families at risk of blindness from rare genetic eye disease

New research has revealed for the first time the number of Australian families affected by genetic mutations that cause the rare genetic eye disease Leber Hereditary Optic Neuropathy (LHON) – and the risk of going blind from the disease.

Researchers identify new gene variants that may cause inherited retinal dystrophies

An international team of researchers, led by scientists at University of California San Diego and Shiley Eye Institute at UC San Diego Health, has broadened and deepened understanding of how inherited retinal dystrophies (IRDs) affect different populations of people and, in the process, have identified new gene variants that may cause the diseases.

Intra-arterial tissue plasminogen activator could help prevent vision loss in patients

Central retinal artery occlusion (CRAO) is a vision-threatening disorder for which there is no well-established treatment. Intra-arterial tissue plasminogen activator (tPA) has the potential to fill that gap but it has to be given in time, according to Gareth Lema, MD, PhD, Senior Faculty, Icahn School of Medicine at Mount Sinai, New York.

Iceland and Norway are the first countries associated to Horizon Europe

Iceland and Norway have formally become associated to Horizon Europe, enabling entities in those two countries to participate in Europe’s €95.5 billion research and innovation programme, under the same conditions as entities from the EU Member States.

Smoking, alcohol intake tied to age-related macular degeneration

Genetically predicted smoking initiation and lifetime smoking are associated with elevated risk of advanced age-related macular degeneration (AMD), while genetically predicted alcohol intake is associated with increased risk of geographic atrophy.

Laser treatment shows potential to transform glaucoma management in Africa

Laser treatment has the potential to transform the management of glaucoma in Africa, and to prevent more people from going irreversibly blind, particularly in regions with high disease prevalence and incidence, suggests new research published in Lancet Global Health.

Closer Collaboration between EC and European Union Intellectual Property Office

The Commission and the European Union Intellectual Property Office commit to closer collaboration on Intellectual Property to support the market uptake of research results

CD146 as a promising therapeutic target for retinal and choroidal neovascularization diseases

Blinding diseases seriously affect quality of life. Retinal and choroidal diseases are common blinding eye diseases with complicated pathogenesis that highly damage visual function. The key factor regulating retinal angiogenesis and vessel maturity is oxygen.

First Place of the OSA2021

Congratulations! After having won the Swiss OpthAward 2021, Magdalena Renner, Head of the IOB Human Organoid Platform won the first place of the VSY Biotechnology Ophthalmology Star Awards (OSA) 2021.